Ankylosing Spondylitis

References

Citations

1. Van der Linden S, et al. (2009). Ankylosing spondylitis. In GS Firestein et al., eds., Kelley's Textbook of Rheumatology, 8th ed., vol. 2, pp. 1169–1189. Philadelphia: Saunders Elsevier.

Other Works Consulted

• Braun J, Sieper J (2004). Biological therapies in spondyloarthritides—The current state. Rheumatology, 43(9): 1072–1084.

• Gorman JD, et al. (2002). Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor a. New England Journal of Medicine, 346(18): 1349–1356.

• Jaakkola E, et al. (2006). Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Annals of the Rheumatic Diseases, 65(6): 775–780.

• McVeigh CM, Cairns AP (2006). Clinical review: Diagnosis and management of ankylosing spondylitis. BMJ, 333(7568): 581–585.

• Zochling J, et al. (2006). ASAS/EULAR recommendations for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases, 65(4): 442–452.

Go to previous section	Go to top of page	Go to next section
Author:	Shannon Erstad, MBA/MPH	Last Updated: May 14, 2009
Medical Review:	Anne C. Poinier, MD - Internal Medicine E. Gregory Thompson, MD - Internal Medicine Richa Dhawan, MD - Rheumatology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.